The Effect of Intermittent Preventive Treatment during Pregnancy on Malarial Antibodies Depends on HIV Status and Is Not Associated with Poor Delivery Outcomes | Zendy

Elisa SerraCasas | Zendy; Clara Menéndez | Zendy; Azucena Bardají | Zendy; Llorenç Quintó | Zendy; Carlota Dobaño | Zendy; Betuel Sigaúque | Zendy; Alfons Jiménez | Zendy; Inácio Mandomando | Zendy; Virander S. Chauhan | Zendy; Chetan E. Chitnis | Zendy; Pedro L. Alonso | Zendy; Alfredo Mayor | Zendy

Open Access

The Effect of Intermittent Preventive Treatment during Pregnancy on Malarial Antibodies Depends on HIV Status and Is Not Associated with Poor Delivery Outcomes

Author(s) -

Elisa SerraCasas,

Clara Menéndez,

Azucena Bardají,

Llorenç Quintó,

Carlota Dobaño,

Betuel Sigaúque,

Alfons Jiménez,

Inácio Mandomando,

Virander S. Chauhan,

Chetan E. Chitnis,

Pedro L. Alonso,

Alfredo Mayor

Publication year - 2009

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1086/648595

Subject(s) - malaria , medicine , sulfadoxine , pregnancy , pyrimethamine , immunology , human immunodeficiency virus (hiv) , chloroquine , malaria prevention , sulfadoxine/pyrimethamine , immunity , virology , population , immune system , environmental health , biology , research methodology , genetics

Intermittent preventive treatment during pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP) is recommended for malaria prevention in sub-Saharan Africa. However, studies reporting the effect of IPTp on malaria-specific immunity are scarce and are based on findings in human immunodeficiency virus (HIV)-negative primigravidae.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research